Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 125.05B | 123.52B | 126.44B | 118.05B | 114.25B | 146.93B |
Gross Profit | 34.12B | 33.37B | 31.74B | 31.91B | 32.41B | 64.79B |
EBITDA | 12.89B | 13.74B | 12.82B | 10.06B | 13.27B | 14.13B |
Net Income | 8.40B | 7.57B | 6.72B | 6.22B | 6.22B | 6.65B |
Balance Sheet | ||||||
Total Assets | 143.09B | 137.09B | 140.23B | 128.98B | 125.41B | 120.04B |
Cash, Cash Equivalents and Short-Term Investments | 14.19B | 19.47B | 22.08B | 25.25B | 26.59B | 23.05B |
Total Debt | 25.63B | 20.30B | 28.09B | 33.69B | 34.58B | 35.26B |
Total Liabilities | 63.89B | 56.82B | 67.54B | 69.08B | 70.27B | 72.36B |
Stockholders Equity | 79.20B | 80.27B | 72.69B | 59.90B | 55.14B | 47.68B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 5.62B | 2.54B | 2.87B | 4.42B | 405.00M |
Operating Cash Flow | 0.00 | 8.50B | 4.62B | 8.17B | 11.31B | 12.16B |
Investing Cash Flow | 0.00 | -2.30B | 843.00M | -5.74B | -6.58B | -11.21B |
Financing Cash Flow | 0.00 | -8.76B | -4.42B | -2.90B | -1.32B | 3.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥79.79B | 9.81 | 1.21% | -2.31% | 12.63% | ||
66 Neutral | ¥64.90B | 9.30 | 1.02% | -5.54% | 3.00% | ||
65 Neutral | $27.28B | 15.30 | -4.01% | 3.16% | 1.00% | 1.98% | |
65 Neutral | ¥24.35B | 38.67 | 1.98% | 0.93% | 330.63% | ||
64 Neutral | ¥23.39B | 17.53 | 1.99% | 6.08% | -22.00% | ||
61 Neutral | ¥254.31B | 16.15 | 1.99% | 25.63% | -24.35% |